Sponsored For
Beginners Choice

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
BP p.l.c is an oil & gas integrated business based in the UK. BP shares (BP) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. BP employs 67,600 staff and has a trailing 12-month revenue of around £205.8 billion.
Since the stock market crash in March caused by coronavirus, BP's share price has had significant negative movement.
Its last market close was £207.75, which is 54.19% down on its pre-crash value of £453.55 and 7.29% down on the lowest point reached during the March crash when the shares fell as low as £222.9.
If you had bought £1,000 worth of BP shares at the start of February 2020, those shares would have been worth £567.49 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £458.92.
Latest market close | 207.75p |
---|---|
52-week range | 184.9827p - 456.0412p |
50-day moving average | 274.5727p |
200-day moving average | 261.3689p |
Wall St. target price | 7.99p |
PE ratio | 20.2373 |
Dividend yield | 0.16p (5.18%) |
Earnings per share (TTM) | 23.4p |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the last close of 207.75p
1 week (2021-01-14) | -32.82% |
---|---|
1 month (2020-12-21) | -19.49% |
3 months (2020-10-21) | 3.90% |
6 months (2020-07-21) | -34.25% |
1 year (2020-01-21) | -57.63% |
---|---|
2 years (2019-01-21) | -60.21% |
3 years (2018-01-19) | -59.26% |
5 years (2016-01-21) | -39.30% |
Valuing BP stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BP's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
BP's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, BP shares trade at around 20x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71).
BP's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.43. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BP's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
BP's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £17.3 billion.
The EBITDA is a measure of a BP's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | £205.8 billion |
---|---|
Gross profit TTM | £45.7 billion |
Return on assets TTM | -1.43% |
Return on equity TTM | -24.37% |
Profit margin | -10.52% |
Book value | 3.356p |
Market capitalisation | £61.5 billion |
TTM: trailing 12 months
Steps to owning and managing Vaxart shares from Ireland.
Steps to owning and managing Takeda Pharmaceutical shares from Ireland.
Steps to owning and managing Sinovac Biotech Ltd shares from Ireland.
Steps to owning and managing Mesoblast shares from Ireland.
Steps to owning and managing Inovio Pharmaceuticals shares from Ireland.
Steps to owning and managing Heat Biologics shares from Ireland.
Steps to owning and managing CytoDyn shares from Ireland.
Steps to owning and managing Cynata Therapeutics shares from Ireland.
Steps to owning and managing BioNTech shares from Ireland.
Steps to owning and managing Atomo Diagnostics shares from Ireland.